Legend Biotech Corp Cash Flow Quality Index

Latest as of June 2026: -0.63x

Legend Biotech Corp cash flow quality index. Legend Biotech Corp (LEGN) has a Cash Flow Quality Index of -0.63x as of June 2026. Operating cash flow of $-20.90 Million is below net income of $33.20 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of Legend Biotech Corp to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.63x
Operating CF / Net Income

Operating Cash Flow

$-20.90 Million
USD

Net Income

$33.20 Million
USD

Data as of

Jun 2026
Most recent filing

Cash Flow Quality Index of Legend Biotech Corp (2017–2017)

Cash flow quality index of Legend Biotech Corp from 2017 to 2017. Historical Cash Flow Quality Index for Legend Biotech Corp across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Legend Biotech Corp cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Legend Biotech Corp Cash Flow Quality Index by Year (2017–2017)

Legend Biotech Corp cash flow quality index by year from 2017 to 2017. Year-by-year earnings quality comparison for Legend Biotech Corp. For the full cash flow conversion analysis, see LEGN cash generation efficiency.

Year Quality Index Operating CF (USD) Net Income YoY Change
2017 -0.25x $-2.38 Million $9.37 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.